Find your path to Marguerite
557 people in our graph share verified history with Marguerite — schools, employers, funds. One of them is your warm intro.
Madison LenormandunlockedMarguerite: together at Imperial College London (2017–2018)
×2Marguerite: together at University of Cambridge
×3Marguerite: together at Brown University
×5Marguerite: together at Imperial College London
About
Marguerite Colin is a PhD student at the MRC Toxicology Unit in Cambridge, where she studies the toxicity of nucleic acid-based therapeutics in cardiac models in collaboration with industry. She has prior experience in early-stage life sciences investment and works in molecular biology and drug discovery. She holds a BSc from Imperial College London and an MPhil in Therapeutic Sciences from the University of Cambridge.
Invests in
Biotech
Experience
- Creator FundStudent Investment Partnercurrent2025 — present
- Creator FundVenture Fellow2024 — 2025Cambridge, England, United Kingdom
- University of CambridgeDoctoral Studentcurrent2023 — presentMRC Toxicology, Cambridge, UK
- Start CodonVenture Scholar2023Cambridgeshire, England, United Kingdom
- Start CodonVenture Promoter2021 — 2022Cambridge, England, United Kingdom
- MRC Toxicology UnitResearch Assistant2022 — 2023Cambridge, England, United Kingdom
- Sofinnova PartnersAnalyst Intern2021Paris, Île-de-France, France
- CandesicAnalyst2020 — 2021London, England, United Kingdom
- Imperial College LondonUndergraduate Research Assistant2019London, United Kingdom
- Imagine Institute of Genetic DiseasesResearch Intern2018Paris Area, France
Skills & more
Scientific WritingBioinformatics
Languages English · French · Spanish
- Scientific French Baccalaureate - Highest Honours — La Rochefoucauld - Lycée
From Marguerite's professional profile.
Colleagues at Creator Fund
Al Giles
Investor at Creator Fund
Alexandra Ntemourtsidou
COO at Creator Fund
Ben Stewart
Investor at Creator Fund
Callum Hill
Associate at Creator Fund
Erica Olsen
Investor at Creator Fund
Fabian Bäzner
Investor at Creator Fund
Henry Lane Fox
Chief Executive Officer, Founder at Founders Factory
Jamie Macfarlane
CEO at Creator Fund
Frequently asked questions
- Who is Marguerite Colin?
- Marguerite Colin is a PhD student at the MRC Toxicology Unit in Cambridge, where she studies the toxicity of nucleic acid-based therapeutics in cardiac models in collaboration with industry. She has prior experience in early-stage life sciences investment and works in molecular biology and drug discovery. She holds a BSc from Imperial College London and an MPhil in Therapeutic Sciences from the University of Cambridge.
- Where does Marguerite Colin work?
- Marguerite Colin is at Creator Fund.
- What does Marguerite Colin invest in?
- Marguerite Colin invests in Biotech.
- Where did Marguerite Colin go to school?
- Marguerite Colin studied at University of Cambridge (Doctor of Philosophy - PhD, Biology/Biological Sciences); University of Cambridge (Master of Philosophy - MPhil, Therapeutic Sciences); Imperial College London (Bachelor of Science - BS, Biology/Biological Sciences).
Same school
Also attended University of Cambridge1,581
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosFounder and Managing Partner of VerdictGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
+ 1,575 more
Also attended Imperial College London813
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at MedicxiBen PerryInvestor at Medicxi
+ 807 more
Also attended Brown University727
Theresia GouwFounding Partner at Acrew CapitalJoe GebbiaCo-founder of AirbnbDylan FieldCo-founder, CEO & Chair of FigmaAlexis AbramsPartner, General Counsel at Felicis VenturesJohn KimInvestor Relations at General CatalystAli Fisher SweetInvestor at Index Ventures
+ 721 more
Shared employers
Also worked at Creator Fund31
Naseem MoumeneVice President at Northzone, investing across complex and fragmented industries undergoing fundamental shiftsHugo SilvaPartner at Pi LabsNayanika BhallaInvestor at IndustrifondenJai TaylorInvestor at Blue Wire CapitalPhilip WinterEntrepreneur in Residence at Cambridge Innovation CapitalHenry Lane FoxChief Executive Officer, Founder at Founders Factory
+ 25 more
Also worked at University of Cambridge283
Masha LevinVenture Partner at One Way VenturesChris WeyrerPrincipal at Vida VenturesAnnie DongInvestor at Dorm RoomFrancesco PomponiInvestor at Extantia CapitalJonathan RobinsonSenior Independent Director at EMV CapitalPhilip KalikmanAssistant Professor of Real Estate, Finance, & Economics at Joyance Partners
+ 277 more
Also worked at MRC Toxicology Unit1
Also worked at Sofinnova Partners73
Anne HorganPartner at Cambridge Innovation CapitalLaetitia SchwabPrincipal at SR One Capital ManagementAntoine Papiernik PapiernikChairman and Managing Partner at Sofinnova PartnersGraziano SeghezziManaging Partner at Sofinnova PartnersMichael KrelPartner at Sofinnova PartnersHenrijette RichterManaging Partner at Sofinnova Partners
+ 67 more